Sandoz Scientific Standalone Event in Russia “Combat Infections to Save Lives”
Nov 15, 2017
Sandoz Scientific Standalone Event “Combat Infections to Save Lives” aims at increasing access to information in the field of antibiotic therapies in Central & Eastern Europe and Middle East & Africa (CEEMEA)
First event in the field of anti-infectives is utilizing digital platforms to reach healthcare professionals with state-of-art information shared by internationally recognized and trusted experts.
Holzkirchen, November 15, 2017– Sandoz is holding today a Scientific Standalone Event “Combat Infections to Save Lives” in Moscow, Russia. This event aims to increase access to valuable medical information in the field of antibiotic therapies to healthcare professionals across the CEEMEA region.
Ahead of the event Francesco Balestrieri, Head of Sandoz CEEMEA said: “Our goal at Sandoz is to increase access to high-quality medicines, medical information and medical capacity to millions of people every year. To achieve this we are constantly looking for new and innovative ways to engage with the medical community.” He added: “This event on anti-infectives is testimony of our commitment to make medical information available to as many specialists as possible. We fundamentally believe that health outcomes for patients can be improved if more people are better trained to prevent, diagnose, treat diseases appropriately and to consider rational use of antibiotics to safeguard effectiveness of these essential and valuable therapies long term worldwide.”
It is a commonly recognized fact that mortality due to infectious diseases is a leading cause of death in low income countries. However, huge concern is that lower respiratory tract infections are the third biggest killer after cardiovascular diseases and stroke worldwide, regardless of country income1. There are different reasons for such alarming statistics, but they can be highlighted with two common denominators. One important factor is the lack of access to medical knowledge and to effective medicines and the other increasing antimicrobial resistance and void of the discovery of new antibiotics. Several initiatives are ongoing to address the global problem of antimicrobial resistance. One of them is World Antibiotic Awareness Week which is taking place right this week2,3. This year the motto k is “Think Twice. Seek Advice.” Sandoz as an important player in the field of anti-infectives and also a company discovering first oral penicillin is taking part in this initiative. Rational use of antibiotics as leading topic is well in line with the motto of this year’s World Antibiotic Awareness Week3. To address major reasons of high mortality due to lower respiratory tract infections Sandoz is in close collaboration with local medical doctors’ communities from CEEMEA countries. Together we have chosen four focus topics for the event:
Rational use of antibiotics – Why does it matter?
Sinus infections – When should we worry?
Community acquired pneumonia – Old challenges and new solutions
Antibiotics & bronchitis – What do the guidelines tell us?
The “Combat Infections to Save Lives” event will be organized on-site in Moscow and broadcasted to ten countries in the CEEMEA region simultaneously. In these remote locations, local KOLs are invited to attend the event and apply the knowledge in clinical practice in the best interest of patients.
About Sandoz Sandoz is a global leader in generic pharmaceuticals and biosimilars. As a division of the Novartis Group, our purpose is to discover new ways to improve and extend people’s lives. We contribute to society’s ability to support growing healthcare needs by pioneering novel approaches to help people around the world access high-quality medicine. Our portfolio of approximately 1000 molecules, covering all major therapeutic areas, accounted for 2016 sales of USD 10.1 billion. In 2016, our products reached well over 500 million patients and we aspire to reach one billion. Sandoz is headquartered in Holzkirchen, in Germany’s Greater Munich area.